IsobonducellinCAS# 610778-85-3 |
2D Structure
- Bonducellin
Catalog No.:BCN6823
CAS No.:83162-84-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 610778-85-3 | SDF | Download SDF |
PubChem ID | 10423880 | Appearance | Yellow powder |
Formula | C17H14O4 | M.Wt | 282.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3Z)-7-hydroxy-3-[(4-methoxyphenyl)methylidene]chromen-4-one | ||
SMILES | COC1=CC=C(C=C1)C=C2COC3=C(C2=O)C=CC(=C3)O | ||
Standard InChIKey | DLQSYZMPSWHYMW-WQLSENKSSA-N | ||
Standard InChI | InChI=1S/C17H14O4/c1-20-14-5-2-11(3-6-14)8-12-10-21-16-9-13(18)4-7-15(16)17(12)19/h2-9,18H,10H2,1H3/b12-8- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Isobonducellin exhibits potent cytotoxic activity in Jurkat and HepG2 cells, while moderate growth inhibition against Colon205 cells. |
Targets | Antifection |
Isobonducellin Dilution Calculator
Isobonducellin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.5423 mL | 17.7117 mL | 35.4233 mL | 70.8466 mL | 88.5583 mL |
5 mM | 0.7085 mL | 3.5423 mL | 7.0847 mL | 14.1693 mL | 17.7117 mL |
10 mM | 0.3542 mL | 1.7712 mL | 3.5423 mL | 7.0847 mL | 8.8558 mL |
50 mM | 0.0708 mL | 0.3542 mL | 0.7085 mL | 1.4169 mL | 1.7712 mL |
100 mM | 0.0354 mL | 0.1771 mL | 0.3542 mL | 0.7085 mL | 0.8856 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Boc-His(Nτ-Me)-OH
Catalog No.:BCC2684
CAS No.:61070-22-2
- L-Thyroxine sodium salt pentahydrate
Catalog No.:BCC4283
CAS No.:6106-07-6
- N-Desmethylclozapine
Catalog No.:BCC6887
CAS No.:6104-71-8
- Teicoplanin
Catalog No.:BCC4731
CAS No.:61036-62-2
- c-JUN peptide
Catalog No.:BCC8085
CAS No.:610273-01-3
- Ferulamide
Catalog No.:BCN4129
CAS No.:61012-31-5
- Succinylcholine Chloride Dihydrate
Catalog No.:BCC4564
CAS No.:6101-15-1
- Isoacetovanillone
Catalog No.:BCN7166
CAS No.:6100-74-9
- Tenuazonic acid
Catalog No.:BCN1859
CAS No.:610-88-8
- H-Leu-OH
Catalog No.:BCC2968
CAS No.:61-90-5
- Zoxazolamine
Catalog No.:BCC4751
CAS No.:61-80-3
- 4-Aminohippuric Acid
Catalog No.:BCC4753
CAS No.:61-78-9
- Icotinib
Catalog No.:BCC4473
CAS No.:610798-31-7
- 4-Phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride
Catalog No.:BCC6769
CAS No.:6109-35-9
- Tectoridin
Catalog No.:BCN1020
CAS No.:611-40-5
- (R)-Mandelic acid
Catalog No.:BCN8532
CAS No.:611-71-2
- Bromhexine hydrochloride
Catalog No.:BCC8898
CAS No.:611-75-6
- Epipterosin L 2'-O-glucoside
Catalog No.:BCN4614
CAS No.:61117-89-3
- 3,9-Dihydroxypterocarpan
Catalog No.:BCN4131
CAS No.:61135-91-9
- 6alpha-Hydroxymedicarpin
Catalog No.:BCN3939
CAS No.:61135-92-0
- 4-(3,4-Dihydroxyphenyl)-2-butanone
Catalog No.:BCN4132
CAS No.:61152-62-3
- Grandifloroside
Catalog No.:BCN4133
CAS No.:61186-24-1
- Quinine HCl Dihydrate
Catalog No.:BCC4933
CAS No.:6119-47-7
- Uzarigenin digitaloside
Catalog No.:BCN4613
CAS No.:61217-80-9
Stimulating the production of homoisoflavonoids in cell suspension cultures of Caesalpinia pulcherrima using cork tissue.[Pubmed:15381409]
Phytochemistry. 2004 Sep;65(17):2455-61.
It has previously been demonstrated that cork tissue increases the efficiency of the production of lipophilic secondary metabolites in diverse plant cell suspension cultures. In the present study, three new homoisoflavonoids--named dihydrobonducellin, 2'-methoxydihydrobonducellin, and 2'-methoxybonducellin--and bonducellin and Isobonducellin were isolated from Caesalpinia pulcherrima cultured cells coincubated with cork tissue. Cork tissue increased the production of 2'-methoxybonducellin by about 7-fold relative to control cells, and more than 80% of the product was recoverable from the cork tissue. When cork tissue and methyl jasmonate or yeast extract were added simultaneously to the medium, the amount of 2'-methoxybonducellin produced increased further. The production of the other four homoisoflavonoids was enhanced by variable amounts. Our results indicate that the addition of cork tissue would be an effective technique for investigating formation of secondary metabolites that usually accumulate only in trace amounts.
Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: a comparative study.[Pubmed:17475387]
Food Chem Toxicol. 2007 Sep;45(9):1770-6.
The antioxidant (DPPH radical and superoxide anion scavenging activities), and cytotoxic (in tumor, Jurkat, PC-3, Colon 205, HepG2, and normal PBMCs cells) activities of 16 plant phenolic or related compounds were evaluated in vitro. Different categories compounds corresponding to 10 flavonoids, three lignans, two phenolic acids, and a catechin showed significant mean differences in antioxidant and cytotoxic activities. Particularly, the flavonols, quercetin (3) and tiliroside (11) possess significant antioxidant activity, as well as cytotoxic activity against Jurkat; and Jurkat and HepG2 cells, respectively. In contrast, the flavanone, 5,7-dimethoxy-3',4'-methylenedioxyflavanone (7), and homoisoflavonoid, Isobonducellin (10) shown to have no significant antioxidant activity, but exhibited potent cytotoxic activity in Jurkat and HepG2 cells, while moderate growth inhibition against Colon205 cells. Interestingly, none of these derivatives shown to have toxicity toward normal peripheral blood mononuclear cells, over the concentration range tested (5-200 microM). Cytotoxic activities of some natural flavonoids identified in the medicinal plants were evaluated for the first time.
Flavanoids from Caesalpinia pulcherrima.[Pubmed:12877920]
Phytochemistry. 2003 Aug;63(7):789-93.
Two new flavanoids, 5,7-dimethoxy-3',4'-methylenedioxyflavanone and Isobonducellin along with 2'-hydroxy-2,3,4',6'-tetramethoxychalcone, 5,7-dimethoxyflavone and bonducellin were isolated from the aerial parts of Caesalpinia pulcherrima. The structures of the compounds were settled mainly by interpretation of their 1D and 2D NMR spectra. Isobonducellin was found to be a homoisoflavanoid containing a cis (Z)-double bond. Antimicrobial activity of the new compounds was evaluated.